1142 Generation of tumor-killing iPSC-macrophages through the genetic interrogation of CD47-SIRPa don’t eat me receptor pathway

CD47型 审问 癌症研究 医学 免疫学 免疫系统 政治学 法学
作者
Portia R. Smith,Jue Zhang,Mark E. Berres,Ashley M. Weichmann,Divine Mensah Sedzro,Medha Malik,Igor I. Slukvin
出处
期刊: 卷期号:: A1264-A1264
标识
DOI:10.1136/jitc-2024-sitc2024.1142
摘要

Background

Albeit the remarkable success of treating blood cancers with chimeric antigen receptor (CAR) T cell therapy, solid tumor cancers largely remain resistant to current immunotherapies. Macrophages within the tumor microenvironment (TME) are often polarized into pathogenic tumor-associated macrophages (TAMs), implicated in the inhibition of cytotoxic lymphocytes and blockade of macrophage-driven antitumor functions. Although TAMs are often highly involved in growth and survival of the tumor, macrophages have unique access to the TME and are highly communicative to surrounding immune cells, making them an attractive candidate for solid tumor immunotherapy. Many tumors over-express the ‘don’t eat me’ receptor CD47, recognized by macrophage receptor SIRPa. When SIRPa binds to CD47, it blocks macrophage-driven phagocytosis, thus protecting CD47+ cells from destruction.

Methods

To overcome this, we hypothesized knocking-out the ‘don’t eat me’ receptor SIRPa in human induced pluripotent stem cells (iPSCs) to generate macrophages with superior antitumor functions against solid tumor cancers. We have found through CRISPR/Cas9 genetic engineering that SIRPa-knockout (KO) iPSC-Macrophages (iMacs) have significantly increased antibody-dependent phagocytosis and cytotoxicity against SKOV-3 ovarian cancer, MCF7 breast cancer, and WM266-4 melanoma cancer cell lines than WT iMacs in vitro.

Results

Furthermore, during an in vitro exhaustion study, SIRPa-KO iMacs that were re-challenged with fresh SKOV-3 + anti-HER2 five times every 24 hours remained active and reduced the overall tumor burden significantly more than WT iMacs. Together, these results support that SIRPa-KO iMacs have superior anti-tumor capacity and significantly enhance the anti-tumor effects of monoclonal antibody (mAb) therapy. Additionally, SIRPa was knocked-out of GD2-CAR-expressing iPSCs to generate SIRPa-KO GD2-CAR iMacs to use against GD2+ solid tumors. Our preliminary in vitro results show increased tumor-killing of WM266-4 GD2+ melanoma by SIRPa-KO GD2-CAR iMacs compared to GD2-CAR iMacs. Using NSG and NCG-X mouse models, luciferase-expressing human solid tumor cell lines are engrafted in the peritoneal cavity or intravenously to recapitulate metastatic growth in the lungs. These xenograft models are currently being assessed for the antitumorigenic properties of SIRPa-KO iMacs and SIRPa-KO GD2-CAR iMacs. Our preliminary results suggest that SIRPa-KO iMacs + anti-HER2 treatment provide the longest survival compared to all other treatment groups, regardless of if they were administered via IV or IP injection.

Conclusions

In conclusion, we have found that multiplex genetic editing involving knocking-out SIRPa and knocking-in GD2-CAR in human iPSCs produce functional macrophages with superior capacity for antitumorigenic activities against solid tumor cancers and have potential for clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Xyy628完成签到 ,获得积分10
刚刚
方文琛完成签到,获得积分10
1秒前
aiomn完成签到 ,获得积分10
1秒前
彩色的书兰完成签到 ,获得积分10
3秒前
毛血旺发布了新的文献求助10
3秒前
4秒前
DHQ完成签到,获得积分10
4秒前
打打的应助被Seven采纳,获得10
5秒前
6秒前
深情安青的应助被xu采纳,获得10
7秒前
Hello的应助被Xyy628采纳,获得10
7秒前
8秒前
8秒前
Jasper的应助被dmdgling采纳,获得10
8秒前
yang666发布了新的文献求助10
9秒前
SYX完成签到,获得积分10
10秒前
12秒前
梵高的向日葵完成签到,获得积分10
12秒前
Ava的应助被宇智波小小怪采纳,获得10
12秒前
sagitar的应助被哈哈采纳,获得20
12秒前
俏皮夏菡发布了新的文献求助20
12秒前
123564举报苹果的求助涉嫌违规
13秒前
13秒前
坚强孤容发布了新的文献求助10
14秒前
14秒前
yang666完成签到,获得积分10
14秒前
16秒前
17秒前
18秒前
灰白发布了新的文献求助30
19秒前
20秒前
欣喜雨真完成签到,获得积分10
22秒前
xixi完成签到,获得积分10
23秒前
高瑛键完成签到,获得积分10
23秒前
聪明的行云完成签到 ,获得积分10
23秒前
cy发布了新的文献求助10
24秒前
Hello的应助被mooncake187采纳,获得10
24秒前
25秒前
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611